Biomarker Xplorer
The power of multi-omics for biomarker discovery

3
Analysis Levels Covered
>95%
Alignment rate to the reference transcriptome
20k+
Genes profiled per sample
Use Cases & Applications
-
Oncology & Cancer
-
Rare & Genetic Diseases
-
Immunology & Inflammation
-
Pharmacogenomics & Treatment Response
-
Experimental Models & CRISPR Validation
-
Translational Research & Precision Medicine
-
Neurology & Neurodegeneration
-
Environment / Microbiota
-
Molecular Toxicology
Why Choose Our Biomarker Xplorer Package?
✅ An integrated and unique multi-omics approach
✅ Actionable data serving your objectives
✅ Tailored scientific support at every stage
✅ Real-world applications, from research to personalized medicine
DNA, RNA, and Proteins powering your discoveries
A multi-omics strategy for a holistic view
The identification and validation of biomarkers are essential in biomedical research, early diagnosis, and personalized medicine.
However, relying on a single data layer (genomics, transcriptomics, or proteomics) greatly limits the ability to capture the full complexity of biological mechanisms.
A solution designed and developed by GENXMAP
Biomarker Xplorer is an integrated multi-omics solution developed by GENXMAP.
It combines the analysis of DNA, RNA, and proteins to precisely decipher the molecular signatures associated with diseases, treatment responses, or various pathophysiological states.
A fully mastered end-to-end workflow
From sample collection to bioinformatics analysis, we integrate every step of the process.
Our workflows are optimized to ensure reliable, reproducible, and actionable data, tailored to systems biology research, translational medicine, and the development of new therapeutic strategies.
Découverte et validation de biomarqueurs
Projet personnalisé et worflow optimisé
1. Isolation and Quality Control of Biomolecules
Rigorous isolation and quality control of DNA, RNA, and proteins to ensure reliable and actionable results across all your omics applications
Applications:
-
Extraction and purification of DNA, RNA, and proteins from diverse matrices: cell cultures, tissues, blood, biofilms, etc.
-
Systematic verification of quality, concentration, and integrity of extracts for RNA-seq, qPCR, genotyping, targeted transcriptomic analyses, or proteomics.
Techniques:
-
Optimized extraction kits with customized protocols depending on sample type and analytical objectives
-
Genomic DNA degradation for RNA extractions
-
Specific purification for proteins
-
Nanodrop: rapid measurement of concentration and purity (260/280 and 260/230 ratios for DNA/RNA, and 280 for proteins)
-
Qubit: sensitive and precise quantification of DNA, RNA, or proteins, even at low concentrations
-
Fragment Analyzer or TapeStation: evaluation of nucleic acid integrity (RIN/RQN for RNA), essential prior to RNA-seq and transcriptome analyses
2. Discovery of Biomarkers
Identification of expression profiles via Bulk RNA-Seq or Single-cell RNA-Seq to reveal molecular signatures associated with your conditions of interest
Applications:
-
Detection and characterization of biomarkers from global or targeted transcriptomic analyses
-
Comparison of experimental groups (patients vs controls, treated vs untreated, etc.) to identify differentially expressed genes (DEGs) and molecular signatures associated with pathologies, treatments, or biological states
-
Adaptable to a wide variety of sample types: tissues, cell cultures, blood, biofilms, etc.
Techniques:
-
Bulk RNA-Seq: for global expression profiling of complex samples
-
Single-cell RNA-Seq: to explore cellular heterogeneity and identify specific subpopulations or rare molecular signatures
-
Dedicated bioinformatics analysis: to identify DEGs, explore enriched signaling pathways, and highlight associated biological signatures
-
Systematic quality control of data (RNA RIN/RQN, sequencing quality, mapping and expression metrics)
3. Integrated Bioinformatics and Multi-omics Analysis
Integrated bioinformatics and multi-omics analyses to uncover molecular signatures and biological pathways with precision.
Applications:
-
Integration of genomic, transcriptomic, and proteomic data for a holistic interpretation of biological mechanisms
-
Identification of molecular signatures associated with diseases, therapeutic responses, or physiological states
-
Comparative analyses across cohorts, conditions, or treatments
-
Functional interpretation of multi-omics datasets to discover biomarkers and biological pathways of interest
Techniques:
-
NGS data processing pipelines: quality control, trimming, alignment, and quantification
-
Multi-omics integration approaches: combining DNA, RNA, and protein data for cross-layer interpretation
-
Differential analysis and clustering: identification of discriminant features across groups
-
Functional annotation & pathway enrichment: leveraging reference databases (GO, KEGG, Reactome, STRING)
-
Exploratory statistics and data visualization: PCA, heatmaps, networks, and dimensionality reduction plots
-
Custom bioinformatics reporting: standardized outputs, interactive visualizations, and publication-ready figures
4. Validation of Targeted Biomarkers
Confirmation of differential expression of identified biomarkers using qPCR, NanoString, or other suitable technologies
Applications:
-
Validation of molecular signatures or candidate genes selected after RNA-Seq or Single-cell RNA-Seq
-
Comparative analysis of gene expression across experimental groups (disease, treatment, biological conditions, etc.)
-
Accurate quantification of gene expression of targets of interest in additional samples or extended cohorts
Techniques:
-
qPCR (endpoint or real-time RT-qPCR): rapid and sensitive validation of biomarker expression
-
dPCR (digital PCR): ultra-sensitive and absolute quantification of biomarker expression, particularly suited for rare transcripts, circulating DNA/RNA, or low-concentration samples; ideal for clinical or preclinical applications requiring very low detection thresholds
-
FlowCytometry or Imaging (Confocal Microscopy)
-
Western Blot / ELISA: biomarker validation at the protein level when required
-
Systematic quality control of samples and data (purity, concentration, reverse transcription efficiency, standard curves, internal controls)
5. High-throughput Screening and Custom Targeted Panels
Simultaneous analysis of predefined or customized biomarker panels for fast and structured screening
Applications:
-
Targeted research and confirmation of candidate biomarkers across large sample cohorts
-
Rapid screening of expression profiles or genetic variations associated with pathologies, therapeutic responses, or specific physiopathological states
-
Applicable to diverse matrices: tissues, serum, cell cultures, circulating DNA/RNA, etc.
Techniques:
-
Multiplex qPCR panels: simultaneous screening of multiple biomarkers from small sample quantities
-
PCR arrays or NGS amplicon panels: targeted analysis of specific gene panels (e.g., inflammation, oncology, neurodegeneration)
-
Multiplex ELISA: simultaneous analysis of multiple protein biomarkers in plasma, serum, or cell lysates
-
Data quality control and statistical reporting: identification of significant variations and relevant expression profiles
Our All-in-One Packages
Optimized, ready-to-use workflows...
Our solutions, your project!
Check our shop for pricing and ordering options.
*For any order ≥ 16 samples
Proposed Configuration
-
Target: Global transcriptome (bulk RNA-seq) + targeted gene and protein panel
-
Samples: Fresh tissues, FFPE, biopsies, PDX
-
Methodology:
-
RNA extraction & quality control
-
RNA-seq library preparation & quality control
-
Illumina sequencing (2x100, ~50M reads/sample)
-
Targeted qPCR Validation (5 genes of interests)
-
Targeted protein panel: multiplex ELISA
-
-
Analyses: Normalization → differential expression → GO/KEGG enrichment → immune signatures (tumor microenvironment, cytokine activity)
-
Deliverables: FASTQ files, count matrix, differential expression tables, visualizations (heatmaps, volcano plots, PCA), and a comprehensive PDF report.
-
Included: Scientific interpretation meeting (60 min)
Options: Spatial transcriptomics, scRNA-seq, WES (mutations), TCR/BCR-seq, validation by dPCR
Check our shop for pricing and ordering options.
*For any order ≥ 16 samples
Proposed Configuration
-
Target: Global transcriptome (RNA-seq) + coding exome (WES)
-
Samples: Whole blood, PBMC, targeted tissues, cell lines
-
Methodology:
-
RNA & DNA extraction + quality control (RIN ≥8; DIN ≥7)
-
Library preparation for RNA-seq + WES
-
Sequencing: RNA-seq (~40–50M reads) + WES (Illumina, average coverage 100×)
-
-
Analyses: Differential expression → co-expression → exonic variant calling → cross-prioritization (clinical-genetic databases)
-
Deliverables: FASTQ files + expression matrices + VCF files + integrated report (candidate genes & pathways)
-
Included: Scientific interpretation meeting (30–60 min)
Options: miRNA-seq, targeted long reads, validation of rare variants (dPCR, Sanger)
Check our shop for pricing and ordering options.
*For any order ≥ 8 samples
Proposed Configuration
-
Target: Single-cell gene expression profiling (with protein confirmation)
-
Samples: PBMC, inflammatory biopsies, BAL (bronchoalveolar lavage)
-
Methodology:
-
Quality control: cell viability ≥80%, RNA RIN adapted
-
Library preparation: scRNA-seq (10x Genomics)
-
Cytokine profiling: multiplex ELISA for major secreted cytokines
-
Sequencing: scRNA-seq (~5–10k cells/sample)
-
-
Analyses: Clustering + cell annotation → DEGs per cluster → pathway scoring (inflammation, cytokines) → trajectory inference
-
Deliverables: Analyzable objects (.h5ad/.rds) + UMAP/t-SNE plots + marker tables + PDF report
-
Included: Scientific interpretation meeting (30–60 min)
Options: CITE-seq (RNA + proteins), TCR/BCR-seq, spatial transcriptomics, multiplex cytokine profiling
Check our shop for pricing and ordering options.
*For any order ≥ 16 samples
Proposed Configuration
-
Target: Transcriptional and proteomic response to treatment
-
Design: Comparative pre/post-treatment ± controls; ≥3 replicates per condition
-
Methodology:
-
RNA-seq sequencing (~30–40M reads/sample)
-
Label-free proteomic analysis (mass spectrometry)
-
-
Analyses: Predictive signatures → response models → pharmacodynamic genes/pathways → transcriptome↔proteome correlations
-
Deliverables: Normalized matrices (RNA + proteins), classifiers/ROC curves (if applicable), decision-oriented PDF report
-
Included: Scientific interpretation meeting (30–60 min)
Options: WES (resistance), dPCR/qPCR follow-up, L1000-like panels, time-series analyses
Our solutions
Precise and advanced services, cutting-edge technologies, and reliable analyses.
Our rigorous approach ensures detailed results, essential for your scientific discoveries and clinical applications.











